From Eye Care to Hair Growth: Bimatoprost

    April 2024 in “Pharmaceuticals
    Marco Zeppieri, Caterina Gagliano, Leopoldo Spadea, Carlo Salati, Ekele Chukwuyem, Ehimare S. Enaholo, Fabiana D’Esposito, Mutali Musa
    Image of study
    TLDR Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.
    Bimatoprost, originally developed for eye care, has shown potential in promoting hair growth and treating alopecia and hypotrichosis by stimulating the hair cycle and prolonging the growth phase. It's also effective in reducing intraocular pressure (IOP), making it a first-line treatment for glaucoma and ocular hypertension. Studies have shown its efficacy for up to three years with minimal tolerance reports. Bimatoprost, often combined with timolol, has been found to be more effective in mean IOP control than other combinations. However, it's associated with higher costs and side effects such as ocular hyperemia, human corneal endothelium cytotoxicity, and sunken eyelids. Despite these, it's considered safe for breastfeeding mothers and has been approved by the FDA for hair growth treatment. Future perspectives include exploring novel delivery systems to enhance drug efficacy and patient comfort.
    View this study on mdpi.com →

    Cited in this study